As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's ...

Digital health equity gaps exist in patient portal engagement, even among older adults with chronic conditions who could ...

Mavacamten is a selective, reversible, allosteric cardiac myosin inhibitor. It is approved under the brand name Camzyos ® for the treatment of adults with symptomatic New York Heart Association class ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

Objective: To understand patient portal engagement stratified by patient characteristics among adults 50 years and older with at least 1 common chronic medical condition using electronic health ...

A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for ...

Mass General Brigham and Tampa General will co-brand clinical offices in Palm Beach, Martin and St. Lucie counties.

The region’s health systems are facing challenges around Sacramento’s sudden population boom and aging demographics, while ...

First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

The 43-day shutdown of the U.S. government in October and November 2025 complicated lots of things for lots of people, and ...

Health systems are entering an era of intelligent data management where real-time validation, data quality scoring and robust ...